Severe acute respiratory syndrome coronavirus 2 vaccine breakthrough infections: A single metro-based testing network experience
ObjectivesUnderstanding the incidence and characteristics that influence severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine breakthrough infections (VBIs) is imperative for developing public health policies to mitigate the coronavirus disease of 2019 (COVID-19) pandemic. We examine...
Main Authors: | Samantha S. Strickler, Annette Esper, Leona Wells, Anna Wood, Jennifer K. Frediani, Eric Nehl, Jesse J. Waggoner, Paulina A. Rebolledo, Joshua M. Levy, Janet Figueroa, Thanuja Ramachandra, Wilbur Lam, Gregory S. Martin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.1031083/full |
Similar Items
-
Breakthrough Infections: A Challenge towards Measles Elimination?
by: Clara Fappani, et al.
Published: (2022-08-01) -
COVID–19 breakthrough infection after four doses of the vaccines: A case report
by: Hongrang Zhou, et al.
Published: (2023-01-01) -
Pneumococcal Vaccine Breakthrough and Failure in Infants and Children: A Narrative Review
by: Kristen Feemster, et al.
Published: (2023-11-01) -
Characterization of Rotavirus Strains Responsible for Breakthrough Diarrheal Diseases among Zambian Children Using Whole Genome Sequencing
by: Innocent Mwape, et al.
Published: (2023-11-01) -
Cellular and Humoral Immune Responses after Breakthrough Infection in Patients Undergoing Hemodialysis
by: Masataro Toda, et al.
Published: (2023-07-01)